Latest News and Press Releases
Want to stay updated on the latest news?
-
Brookfield, WI, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT) today announced that leading health expert, functional medicine clinician, and media...
-
VANCOUVER, British Columbia and BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
-
- PROCLAIM-CX-2009 Dose Escalation Study Demonstrates Anti-Tumor Activity in Multiple Tumor Types - - Preclinical Studies Suggest Role of CD166 Expression Level in Anti-Cancer Activity and Potential...
-
EFFINGHAM, Ill., April 02, 2019 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue its first quarter 2019 financial results after market close on...
-
NORCROSS, Ga., April 02, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold...
-
Initial Order from New International Police Services Customer for Guns and Ammunition Booked Through Lamperd Distributor Security PRO USA SARNIA, Ontario, April 02, 2019 (GLOBE NEWSWIRE) -- via...
-
Lompoc, CA, April 02, 2019 (GLOBE NEWSWIRE) -- DenMat Holdings, LLC (“DenMat”) today announced the release of the new LumiSmile® mobile application available now in the Apple App Store. LumiSmile is...
-
– $175 million committed from investors in private placement offering – – Trading of CYCN begins on Nasdaq today – CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics,...
-
SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences...
-
SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), today announced the initiation of enrollment in a Phase 2b study of dalcinonacog alfa...